Teosyal®
Teosyal® (Teosyal) is a Swiss Teoxane Laboratories (Geneva, founded in 2003) developed Cross-linked hyaluronic acid (HA) gel filler product family.
Real Teosyal® filler treatment cases from our Nanjing clinic
The following are Teosyal dermal filler injection records performed personally by our physician at our Nanjing clinic. All Before & After images are unretouched clinical photographs; every client has signed a written Media Release Form. Teosyal’s core differentiator is Teoxane’s proprietary RHA® (Resilient Hyaluronic Acid) technology — designed to move naturally with high-motion areas such as the corners of the mouth, nasolabial folds, crow’s feet, and perioral region. Natural rebound without distortion during movement; specific results vary by product line (RHA 1–4 / Redensity I–II / Kiss / Ultra Deep), injection depth, anatomy, and individual metabolic rate.
Case 1 · Teosyal® Real Clinical Record
- Ideal client profile
- Asian Female · Fitzpatrick IV
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- HA filler + jawline lifting (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- 9-12 months later for filler touch-up
Case 1: Asian Female · Fitzpatrick IV · Teosyal® as a core component of an Luowei skeletal facial contouring comprehensive plan addressing chin recession, face shape (round/flat/overall contour), jawline sculpting / masseter adjustment, undefined jawline, excess cheek volume / facial fat accumulation, and refined contour (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 2 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick IV
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Thread double eyelid + Botox® + neurotoxin wrinkle treatment + dermal filler, among 14 procedures (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Botox Micro-touch-up at 4 months + HA lip border reinforcement
Case 2: Asian Female · Fitzpatrick IV · Teosyal® as a core component of a comprehensive plan addressing Luowei skeletal facial contouring, marionette lines / downturned mouth corners, skin laxity, facial & neck sagging, facial heaviness / jowling, skin aging, tired / aged / drawn appearance, dull complexion & facial fatigue, upper eyelid ptosis, under-eye bags & dark circles, tear trough, jawline definition, jawline contouring / masseter adjustment, undefined jawline, hollow cheeks · mid-face volume loss, volume loss, refined facial contour, facial sculpting, recessed chin, lip augmentation, lip liftCore component of the combination treatment plan (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic Nanjing
Case 3 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick I
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Juvéderm® + HA lip augmentation + HA nose contouring + Restylane® and 4 more treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 3: Asian Female · Fitzpatrick I · Teosyal® as a core component of the forehead hollowing, skin laxity, lip augmentation, thin lips, lip reshaping, pouty lips, smile lips, and temporal hollowing combination treatment plan (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic Nanjing
Case 4 · Teosyal® Real Treatment Documentation
- Ideal client profile
- Asian Male · Fitzpatrick I
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Thread Double Eyelid + Filler Chin Augmentation + dermal fillers and 11 other treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 4: Asian Male · Fitzpatrick I · Teosyal® as a core component of the face shape (round/flat/facial contour), ptosis (upper eyelid droop), jawline sculpting/masseter adjustment, undefined jawline, recessed chin, refined nose shape, and flat/low nasal bridge combination treatment plan (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic Nanjing
Case 5 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick I
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Filler Rhinoplasty (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- 12-18 months later for filler touch-up
Case 5: Asian Female · Fitzpatrick I · Teosyal® as a core component of a comprehensive treatment plan addressing: refined nose shape, ptosis (upper eyelid droop), tear troughs, flat / low nasal bridge (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 6 · Teosyal® Real Clinical Record
- Ideal client profile
- Asian Female · Fitzpatrick I
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Chin augmentation with filler + dermal filler + Juvéderm® + non-surgical rhinoplasty with filler and 10 additional treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 6: Asian Female · Fitzpatrick I · Teosyal® as a core component of the face shape (round/flat/facial contour), ptosis (upper eyelid droop), under-eye bags & dark circles, tear trough, jawline definition, undefined jawline, refined contour, recessed chin, refined nose shape, and flat/low nasal bridge combination treatment plan (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic Nanjing
Case 7 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick IV
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Filler Chin Augmentation + Filler Temple Augmentation + Juvéderm® + Teosyal® and 3 more treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 7: Asian Female · Fitzpatrick IV · Teosyal® as a core component of a comprehensive plan addressing tired / aged / drawn appearance, upper eyelid ptosis, under-eye bags & dark circles, tear trough, volume loss, and recessed chin (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 8 · Teosyal® Real Clinical Record
- Ideal client profile
- Asian Female · Fitzpatrick IV
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Thread double-eyelid + dermal filler + Teosyal® + collagen (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 8: Asian Female · Fitzpatrick IV · Teosyal® as a core component of a comprehensive plan addressing thread double-eyelid, upper eyelid ptosis, under-eye bags & dark circles, and tear trough (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 9 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick IV
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Thread double eyelid + HA fillers + Juvéderm® + Stylage® and 5 more treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 9: Asian Female · Fitzpatrick IV · Teosyal® as a core component of a comprehensive plan addressing thread double eyelid, upper eyelid ptosis, and refined nose shape (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 10 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick IV
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- PicoSure® + PicoSure Pro® + PicoWay® + Thread Double Eyelid and 16 other treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Botox Micro-touch-up at 4 months + HA lip border reinforcement
Case 10: Asian Female · Fitzpatrick IV · Teosyal® as a core component of an Luowei skeletal facial contouring comprehensive plan addressing freckles, nasolabial folds, marionette lines / drooping mouth corners, upper eyelid ptosis, under-eye bags & dark circles, tear trough, face shape (round/flat/overall contour), jawline sculpting / masseter adjustment, undefined jawline, excess cheek volume / facial fat accumulation, volume loss, refined contour, and facial contouring & slimming (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic Nanjing
Case 11 · Teosyal® Real Treatment Documentation
- Ideal client profile
- Asian Female · Fitzpatrick IV
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- HA fillers + Juvéderm® + Stylage® + Teosyal® and 5 more treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Botox Micro-touch-up at 4 months + HA lip border reinforcement
Case 11: Asian Female · Fitzpatrick IV · Teosyal® as a core component of the Luowei skeletal facial contouring, facial laxity/jowling, skin aging, facial fatigue/tired appearance, dull complexion, ptosis (upper eyelid droop), under-eye bags & dark circles, tear trough, face shape (round/flat/facial contour), jawline definition, jawline sculpting/masseter adjustment, undefined jawline, and refined contour combination treatment plan (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic Nanjing
Case 12 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick IV · Results clearly maintained for nearly 1–2 years
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Pico® Skin brightening & rejuvenation + PicoSure® + PicoSure Pro® + PicoWay® and 9 more treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 12: Asian Female · Fitzpatrick IV · Results lasting approximately 1–2 years · Teosyal® as a core component of a comprehensive treatment plan addressing: tear troughs, pigmentation, dark spots, facial laxity / jowls, dull complexion & tired appearance, ptosis (upper eyelid droop), under-eye bags & dark circles, volume loss, Luowei skeletal facial contouring, forehead hollowing, uneven skin tone (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 13 · Teosyal® Real Clinical Record
- Ideal client profile
- Asian Female · Fitzpatrick IV
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Filler Chin Augmentation + Filler Lip Augmentation + Filler Temple Augmentation and 10 other treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 13: Asian Female · Fitzpatrick IV · Teosyal® as a core component of a comprehensive treatment plan addressing: Luowei skeletal facial contouring, under-eye bags & dark circles, tear troughs, cheek hollowing & mid-face volume loss, overall volume restoration, refined contour, lip augmentation, lip reshaping, temporal hollowing, forehead hollowing (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 14 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick I · Results lasting 5 years
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- PicoSure® + M22® IPL Photofacial (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 14: Asian Female · Fitzpatrick I · Results lasting 5 years · Teosyal® as a core component of a comprehensive plan addressing melasma, freckles, pigmented spots, pigmentation / post-inflammatory hyperpigmentation (PIH), and discoloration (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 15 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick IV · Results sustained nearly 2–3 years
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Dermal fillers + Juvéderm® + Teosyal® + collagen stimulators and 5 other treatments (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Botox Micro-touch-up at 4 months + HA lip border reinforcement
Case 15: Asian Female · Fitzpatrick IV · Results lasting approximately 2–3 years · Teosyal® as a core component of a comprehensive treatment plan addressing: under-eye bags & dark circles, tear troughs, Luowei skeletal facial contouring (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 16 · Teosyal® Real Clinical Record
- Ideal client profile
- Asian Female · Fitzpatrick IV · Results sustained nearly 2–3 years
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- Juvéderm® + Teosyal® + collagen stimulator (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 16: Asian Female · Fitzpatrick IV · Results lasting nearly 2–3 years · Teosyal® as a core component of a comprehensive plan addressing under-eye bags & dark circles, facial fatigue / aged / tired appearance, dull complexion & tired look, tear trough, volume loss, and refined contour (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Case 17 · Teosyal® Real Patient Results
- Ideal client profile
- Asian Female · Fitzpatrick I · Results sustained nearly 2–3 years
- Areas of concern
- Teosyal® HA filler (comprehensive improvement through a multi-modal combination approach)
- Treatment plan
- PicoSure® + M22® IPL Photofacial (multiple sessions within 3 months)
- Improvement results
- Teosyal® Significant improvement with hyaluronic acid · Overall results look natural
- post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintain
- Daily sun protection + monthly at-home skincare + quarterly clinic assessment
Case 17: Asian Female · Fitzpatrick I · Results sustained nearly 2–3 years · Teosyal® as a core component of a comprehensive plan addressing under-eye bags & dark circles, facial heaviness / jowling, upper eyelid ptosis, tear trough, lip augmentation, thin lips, lip reshaping, fuller lips, lip lift, temporal hollowing, and forehead hollowing (multiple sessions within 3 months) · Led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
Why Choose Luowei Medical Aesthetics Clinic for Teosyal Filler in Nanjing
The filler defines the possibilities; the physician defines the outcome. Our approach is built on three pillars: deep facial anatomy expertise, extensive experience with Asian facial aesthetics, and a rigorous vascular-avoidance safety protocol — ensuring every syringe of Teosyal RHA Resilient HA is placed with precision at the correct tissue plane.
Teoxane RHA Resilient HA clinical application expert
Our physician has an in-depth understanding of Teoxane Laboratories’ RHA® (Resilient Hyaluronic Acid) technology and the Preserved Network structural theory, including the rheological applications of RHA 1–4 across different dynamic tissue planes — the key to achieving natural recoil in high-motion areas such as the corners of the mouth, nasolabial folds, and perioral region.
Injection specialist for Asian faces
Our physician specializes in the skeletal structure and soft-tissue distribution of Asian faces, with a deep understanding of the anatomical differences in cheekbones, jawline, lip shape, and tear troughs among East Asian patients. Through precise product selection (RHA 1–4 / Redensity I–II / Kiss / Ultra Deep) and layered placement control, he avoids overfilling and dynamic distortion.
Teosyal Full product line available
The clinic is also equipped with RHA 1 / RHA 2 / RHA 3 / RHA 4 + Redensity I (skin-boosting antioxidant treatment) + Redensity II (tear trough specialist) + Kiss (lip specialist) + Ultra Deep (ultra-deep structural support), Full coverage of Teosyal’s complete 8-line portfolio. Our physician selects the most appropriate product based on treatment area, injection depth, and rheological requirements.
Hyaluronidase emergency protocol
stocked on-site at the clinic Hylenex (hyaluronidase) Hyaluronidase, In the event of a rare serious complication such as vascular occlusion, hyaluronidase can immediately dissolve the HA and restore blood flow within the critical 4-hour window. This is a mandatory safety standard for any clinic offering HA filler treatments.
- Developed by Teoxane Laboratories, Switzerland · NMPA-registered— RHA 1-4 NMPA-registered progressively from 2017 to 2020
- Teoxane Authorized Chinese distribution channel— All Teosyal products sourced through a traceable 2–25°C cold chain
- Teoxane 200+ published clinical studies— Available in 80+ countries worldwide
- Multi-brand HA combination treatment capability— Teosyal / Juvéderm/ Restylane/ Belotero All available at the same clinic
- Hylenex Hyaluronidase always on hand for emergency use— 4-hour golden window vascular occlusion emergency response capability
Teosyal® What Is Teosyal Dermal Filler?
Teosyal® (Teosyal) is a Swiss Teoxane Laboratories (Geneva, founded in 2003) developed Cross-linked hyaluronic acid (HA) gel filler product family. Its core differentiating feature is Proprietary RHA® technology (Resilient Hyaluronic Acid) and Preserved Network (preserving the natural network structure) — allowing the filler to recoil naturally with facial expressions without distortion. Note: hyaluronic acid is filler, and Botox® Neuromodulator These serve entirely different functions — neurotoxin relaxes muscles; HA restores volume.
Conventional cross-linked HA breaks down the original long-chain HA structure during manufacturing, requiring a high degree of cross-linking for stability — but this makes the gel stiffer and more prone to visible ridging in high-motion areas. Teoxane’s RHA technology Using Minimal chemical modification + high molecular weight + Preserved Network a manufacturing process that achieves stabilization while minimizing alteration to the HA molecular structure, allowing the gel to Soft and natural at rest, with resilient recoil during movement.
Teosyal Achieve Eight product lines Covering all treatment areas and all tissue depths:RHA 1 / RHA 2 / RHA 3 / RHA 4 (Dynamic gradient filling: RHA 1 for the finest superficial lines → RHA 4 for the deepest structural support)Redensity I (Superficial skin booster with a proprietary blend of 8 amino acids + 3 antioxidants + vitamin complex)Redensity II (NMPA-registered, the world’s first HA specifically indicated for tear troughs)Kiss (lip-specialized formula)Ultra Deep (Deep periosteal structural support, nasal base / jawline).
Teosyal Product Line Technical Specifications
- Active ingredients Cross-linked hyaluronic acid (HA) gel + lidocaine (select formulations)
- Core technique RHA® Resilient HA + Preserved Network
- Mechanism of action Volumetric support + moisture retention + elastic rebound + collagen stimulation
- Onset of results Immediate results visible · Full stabilization at 14 days (true result after swelling resolves)
- Duration of results Kiss 9-12 months · RHA 1–4 / Redensity II: 12–18 months · Ultra Deep: 18–24 months
- NMPA-registered RHA 1-4 Approved progressively from 2017 to 2020 · Redensity II specifically approved for the tear trough
- Volume per syringe 1 ml (RHA / Kiss / Redensity II) / 3 ml (Ultra Deep large syringe)
- Manufacturer Teoxane Laboratories (Geneva, Switzerland)
Teosyal vs Comparison with other HA filler brands
| Brand | Core technique | clinical positioning | Maintain |
|---|---|---|---|
| Teosyal® | RHA + Preserved Network | High-motion areas · Resilient recoil | 12-18 months (RHA long-lasting) |
| Juvéderm® | Vycross / Hylacross | Smooth and long-lasting · Suited for static contouring | 12-24 months |
| Restylane® | NASHA / OBT (XpresHAn) | Particulate structure · Strong lifting support, better suited for static areas | 9-18 months |
| Belotero® | CPM Monophasic multi-density | Softest formulation · targets superficial fine lines | 6-12 months |
Note: RHA = Resilient Hyaluronic Acid · Preserved Network = the retained natural long-chain HA network structure · This is the core property that distinguishes Teosyal from other HA fillers in dynamic facial areas.
Teosyal® RHA How HA filler works
Teosyal RHA Hyaluronic acid is precisely injected into the targeted anatomical plane (subcutaneous / supra-SMAS / supraperiosteal) to create Three-dimensional volumetric support + elastic deformation buffering, simultaneously attracts tissue moisture to restore volume, and stimulates fibroblasts to produce new collagen through mechanical traction. This is a Immediate results + natural movement + long-term tissue remodeling a three-stage process.
Consultation & dynamic anatomical assessment
Our physician conducts an anatomical assessment to evaluate areas of volume loss, bone structure, skin tension, and prior filler history — Teosyal clients in particular are assessed for Dynamic assessment: Having clients perform full facial expressions (wide smile / pout / frown / pucker) to identify which lines deepen dynamically and which are purely static — informing the decision to use RHA alone or in combination with Botox.
Product selection & dosage calculation
Based on the treatment area and goals, our physician selects the appropriate Teosyal product:Superficial fine lines → RHA 1 (thinnest dermal layer)Mid-depth lines / perioral area → RHA 2 Nasolabial folds / dynamic perioral lines → RHA 3 Deep zygomatic / high-volume areas → RHA 4 Tear trough → Redensity II (FDA specific approval)Lip refinement → Kiss Nasal base / jawline → Ultra Deep Skin hydration + antioxidant support → Redensity I.
Anatomical Positioning & Vascular Avoidance
After disinfection, each injection point and high-risk vascular zone is mapped using a medical marking pen. Key avoidance of Facial artery, angular artery, supratrochlear artery, infraorbital artery and other key vessels. Deep-layer filler placement should prioritize the use of 27 G blunt cannula technique (e.g., cheekbones, tear trough, nasolabial folds); lip refinement may combine sharp needle + cannula.
Layered injection & real-time dynamic verification
Teosyal RHA gel is deposited at the pre-planned tissue plane — supraperiosteal / deep fat / deep dermis / superficial dermis — using micro-bolus or retrograde linear technique. After every 0.1–0.2 ml of product is placed, our physician asks the patient to make facial expressions to verify natural recoil in real time.Is the dynamic recoil natural? (This is a real-time verification step unique to Teosyal injections) · Gentle finger-pad massage is applied simultaneously to refine the shape. The full treatment takes 30–60 minutes, including topical anaesthesia time.
Immediate results + settled at 14 days + lasting 12–18 months
Injection complete Immediate visible results, Due to HA’s hydrophilic nature, 10–20% swelling is expected during the first 3–7 days.Final settled shape achieved by day 14. Teosyal RHA The Preserved Network structure allows for more gradual degradation within tissue · Longevity varies by product: Kiss 9–12 months · RHA 1–4 / Redensity II 12–18 months · Ultra Deep 18–24 months.
Bruising and Vascular Occlusion Management
Teosyal Extremely high safety profile, however Bruising, swelling, vascular occlusion remain inherent risks of HA filler treatments. Vascular occlusion, while rare (< 0.05%), is a Most serious complication, These can lead to skin necrosis or blindness. Our physician minimizes these risks through three layers of protection: pre-procedure screening, anatomical vascular avoidance, and an on-hand hyaluronidase emergency protocol.
Pre-procedure anticoagulant screening
Discontinue aspirin, NSAIDs, fish oil, vitamin E, red wine, and ginkgo at least 1 week before treatment to significantly reduce the risk of bruising and hematoma
Anatomical vascular avoidance
Vascular mapping assessed before each needle entry · High-risk zones (nose, tear trough, glabella) prioritize blunt cannula + aspiration test + slow, low-pressure injection
Hylenex Emergency response protocol
Hyaluronidase (Hylenex 150 U/ml) is stocked on-site at all times · Immediate HA dissolution is possible within the critical 4-hour window in the event of vascular occlusion · Restores blood flow promptly
Am I a candidate for Teosyal filler?
You are welcome to do a self-assessment before your consultation; however, final candidacy is determined by our physician through a comprehensive anatomical assessment, medical history review, and evaluation of any prior filler treatments.
You may be a good candidate if…
- Have Nasolabial folds Lines that deepen with movement · patients with pronounced lines when laughing
- Highly expressive professions (teachers / sales professionals / content creators / actors)
- Dynamic lip corner lines / crow’s feet / perioral barcode lines
- Tear trough shadowing + dark circles (Redensity II specialized formula)
- Lip augmentation and refinement (Kiss — stays natural when you talk)
- Nasal base depression / jawline sculpting (Ultra Deep for structural support)
- Seeking superficial skin-boosting + antioxidant treatment (Redensity I)
- Has realistic expectations for natural, dynamic results · Not seeking a “completely static” filler outcome
Treatment is not recommended if any of the following apply…
- Pregnancy or breastfeeding
- Known allergy to hyaluronic acid or lidocaine
- Autoimmune conditions affecting the skin (lupus erythematosus / scleroderma)
- Active infection at the injection site / active herpes simplex outbreak
- Recent injection of non-HA fillers with conflicting materials (PMMA / silicone oil)
- Keloid or abnormal scarring tendency
- Pure dynamic lines with no static component (priority consideration should be given to Botox)
- Patients expecting permanent results (HA fillers are reversible and temporary)
Treatment area × Teosyal product selection × our physician’s protocol
Teosyal Each of the eight product lines is designed for a specific area and injection depth — choosing the wrong product is harder to correct than a dosage error:
| Treatment area | Preferred product | Plane / layer | Typical volume |
|---|---|---|---|
| Very superficial fine lines / perioral barcode lines | RHA 1 | Superficial dermis | 0.5-1 ml |
| Mid-depth fine lines / lip border | RHA 2 | mid-dermis | 0.5-1 ml |
| Nasolabial folds / dynamic lip corner lines | RHA 3 | Deep dermis / subcutaneous | 1 ml / side |
| Cheekbone / large-volume contouring | RHA 4 | Subcutaneous / supraperiosteal | 1-2 ml / side |
| Tear trough / dark circles | Redensity II (FDA specific indication) | Deep supraperiosteal layer | 0.5-1 ml |
| lip augmentation and refinement | Kiss | sub-mucosal lip layer | 0.5-1 ml |
| Nasal base / jawline | Ultra Deep | Deep supraperiosteal layer | 2-4 ml |
| skin hydration + antioxidant | Redensity I | Multiple points in the mid-to-superficial dermis | 1-3 ml (treatment) |
Teosyal® Filler Treatment Planning — Nanjing
Our treatment planning is designed to be safe, predictable, and aligned with your facial anatomy and aesthetic goals. Every treatment plan is personally designed and administered by our physician — never delegated to a technician.
Initial Consultation & Dynamic Anatomical Assessment
Free 30-Minute Consultation · Static and dynamic expression assessment · Review of medical history, current medications, and prior filler history · Baseline photography on file.
Product Selection and Dosage Plan
Our physician calculates the appropriate Teosyal product (RHA 1–4 / Redensity I–II / Kiss / Ultra Deep) and volume (ml) required based on the treatment area and aesthetic goals · A transparent quote is provided for confirmation before proceeding.
14 follow-up appointment · assessment of stable results
A follow-up visit 14 days post-injection to assess the true result once swelling has resolved · Expression testing to verify natural dynamic rebound · If asymmetry or undercorrection is noted, a small touch-up can be performed.
12-18 months of maintenance treatment
Touch-up timing is scheduled according to each product’s metabolic rate · Kiss: 9–12 months · RHA 1–4 / Redensity II: 12–18 months · Ultra Deep: 18–24 months · Ongoing tissue hydration and collagen stimulation are maintained throughout.
Typical treatment cycle timeline
Teosyal This is an immediately visible + periodically maintained treatment. Below is a typical patient timeline from first injection to stable results:
| Key timepoints | Content |
|---|---|
| Day 0 | Free 30-Minute Consultation · Static + dynamic assessment · Product selection + personalized quote |
| on the day of injection | 30-60 minute injection session (including topical anesthetic wait time) · Walk in, walk out |
| D1-D3 | Peak swelling · possible bruising · apply cold compresses · avoid heat exposure |
| D7-D14 | Swelling subsides · results stabilize · 14-day follow-up assessment · expression verification |
| Months 9–12 | Kiss Lips: consider a touch-up |
| Months 12–18 | RHA 1-4 / Redensity II Maintenance top-up for core products · Ultra Deep can be extended to 24 months |
Specific volume, product selection, and treatment intervals are customized by our physician after consultation, based on your treatment area, individual metabolism, and aesthetic goals.
Teosyal® Indications treatable with Teosyal RHA filler
Teosyal Thanks to RHA resilient HA and Preserved Network technology, Teosyal performs exceptionally well in high-motion areas and fine superficial treatments — making it the industry-preferred choice for dynamic lines and tear trough correction.
Dynamic nasolabial folds / lip corner lines
RHA 3 Resilient HA is injected in layered planes within the deep dermis and subcutaneous tissue, smoothing static lines while recoiling naturally with facial expressions — no visible ridging when laughing, which is the most challenging performance benchmark for standard HA fillers in dynamic areas.
RHA 3 1 ml / profile · lasting 12–15 months
Tear trough / dark circles (NMPA-registered indication)
Redensity II is NMPA-registered, the world’s first HA specifically indicated for tear troughs, Deep supraperiosteal blunt cannula injection to improve tear trough shadowing and reduce the tired appearance of dark circles. The risk of the Tyndall effect is significantly lower than comparable products when treating thin Asian skin.
Redensity II 0.5-1 ml · Longevity of 12–18 months
Lip augmentation / refinement
Lip augmentation Specialized product: Teosyal Kiss — precise multi-point sculpting of the vermilion border, Cupid’s bow, and corners of the mouth · Lip shape holds naturally while talking and smiling · Resilient and natural feel.
Kiss 0.5-1 ml · Lasts 9–12 months
Very superficial fine lines / perioral barcode lines
RHA 1 This is Teosyal’s softest, most superficial dermal product, designed specifically for fine surface lines and perioral barcode lines (smoker’s lines) · Multi-point micro-droplet injection technique prevents visible lumping.
RHA 1 0.5-1 ml · Lasts 9–12 months
Zygomatic / mid-face contouring
RHA 4 This is Teosyal’s highest-volume product, injected subcutaneously or supraperiosteally to restore volume to the zygomatic and SOOF regions, enhancing mid-face definition while preserving natural expression.
RHA 4 1-2 ml / side · lasting 15–18 months
Nasal base / jawline / chin
Ultra Deep This is Teosyal’s firmest structural product (available in a 3 ml large-volume syringe), designed for deep supraperiosteal injection to build nasal base support, define the jawline, and project the chin.
Ultra Deep 2-4 ml · Lasting 18–24 months
Skin-boosting + antioxidant (exclusive formula)
Redensity we is Teosyal Exclusively formulated with 8 amino acids + 3 antioxidants + Vitamin B6 superficial skin booster complex formula · Multi-point intradermal injections in the mid-to-superficial dermis to improve skin radiance and hydration.
Redensity I 3 sessions · 4 weeks apart
crow’s feet (combined dynamic and static lines)
RHA 1 / RHA 2 in combination with Botox Combination approach · Neuromodulator addresses the dynamic component; RHA addresses static skin-aging lines · Resilient HA does not compromise natural facial expression.
RHA 1-2 0.5 ml + Botox · Combined longevity of 9–12 months
Teosyal Eight product lines × indications × detailed rheology comparison
| Products | Primary indications | placement / depth | Maintain |
|---|---|---|---|
| RHA 1 | Very superficial fine lines / perioral barcode lines | Superficial dermis (minimal dynamic stress) | 9-12 months |
| RHA 2 | Mid-depth fine lines / lip border | mid-dermis | 12 months |
| RHA 3 | Nasolabial folds / dynamic lip corner lines | Deep dermis / subcutaneous (primary dynamic layer) | 12-15 months |
| RHA 4 | Cheekbone / large-volume contouring | Subcutaneous / supraperiosteal (highest dynamic mobility zone) | 15-18 months |
| Redensity I | skin hydration + antioxidant | Multiple points in the mid-to-superficial dermis | 6-9 Month (treatment) |
| Redensity II | Tear troughs (FDA-designated indication) | Deep supraperiosteal layer | 12-18 months |
| Kiss | lip augmentation and refinement | sub-mucosal lip layer | 9-12 months |
| Ultra Deep | Nasal base / mandible / chin | Deep supraperiosteal structural support | 18-24 months |
Pre-Procedure Instructions · Treatment Process · Post-Procedure Care
Following the pre- and post-care protocol is the key to transforming your Teosyal filler result from “possible bruising and noticeable swelling” into “natural definition and dynamic resilience.” Please read carefully and bring any questions to our physician.
Pre-procedure preparation (1 week before injection)
- Discontinue aspirin / ibuprofen / NSAIDs and blood thinners 1 week prior (if permitted by your physician)
- Discontinue fish oil, vitamin E, ginkgo, garlic, and red wine for 1 week
- Avoid alcohol for 24 hours before treatment · Prevents vasodilation that increases bruising risk
- Disclose all current medications, allergy history, autoimmune conditions, and prior filler history (including non-HA fillers)
- Arrive on the day of injection with a clean face and no makeup
- If you have an important social event (wedding / photoshoot), please schedule your treatment at least 2 weeks in advance to allow sufficient time for swelling to resolve
- Not suitable during pregnancy, breastfeeding, or active illness with fever
During the procedure (30–60 minutes)
- Disinfection + anatomical landmark mapping + static and dynamic dual marking
- Topical lidocaine numbing cream applied for 20–30 minutes (select Teosyal products contain lidocaine)
- 27 G Blunt cannula (deep layers / high-risk zones) or 30G sharp needle (precise lip work)
- Slow, low-pressure retrograde injection technique · Aspiration before each injection to check for vascular placement
- Dynamic expression verification: After every 0.1–0.2 ml placed, the patient is asked to make facial expressions to confirm natural recoil
- Real-time massage and shaping · Ensures even distribution
- Apply cold compress for 5–10 minutes post-injection to reduce swelling
- The entire procedure is performed with the patient seated or semi-reclined · fully awake and communicating throughout
Post-Procedure Care (24 hours + 14 days)
- Within 24 hours: Avoid makeup, rubbing the treated area, and sleeping face-down
- Within 48 hours: Avoid strenuous exercise, saunas, hot springs, and hot yoga
- Within 1 week: Avoid facial massage, beauty treatments, and deep-tissue facial spa services
- Within 2 weeks: Avoid flying (if travel is unavoidable, inform our physician in advance)
- Cold compresses help reduce swelling · Arnica cream / gel can help accelerate bruising resolution
- 14 days post-treatment: in-clinic reassessment · dynamic expression verification · minor touch-up if needed once results have stabilized
- Daily SPF 50+ sun protection helps slow HA degradation · Staying well-hydrated supports optimal HA absorption
- If severe pain, skin blanching / livid discoloration, or any vision changes occur, contact the clinic immediately (vascular occlusion warning).
D0–D30 Complete Recovery Timeline
| duration | What clients should do — and what to avoid |
|---|---|
| D0 (on the day of injection) | Immediate visible results · Cold compress No Makeup No Strenuous exercise · no lying face-down for 24 hours |
| D1-D3 | Peak swelling · possible bruising · continue cold compresses · avoid saunas and hot yoga |
| D4-D7 | Swelling gradually subsides · bruising enters the yellow-brown stage · light makeup may be resumed |
| D8-D14 | Shape approaching stable form · Follow-up at day 14 · Expression testing · Touch-up if needed |
| D15-D30 | Stable phase · True dynamic appearance is visible · Photographs taken for comparison · Normal daily activities can resume |
Teosyal® Advantages of Teosyal filler
The injectable determines what is possible; the physician determines the direction — but a quality product gives the physician more possibilities to work with.
Natural dynamic rebound
RHA Resilient HA moves with facial expressions · No distortion when laughing or talking.
Swiss original formulation technology
Teoxane Swiss originator · Backed by 200+ clinical studies.
Tear trough FDA-designated indication
Redensity II The world’s first NMPA-registered HA specifically indicated for the tear trough.
Eight product lines
RHA 1-4 + Redensity I/II + Kiss + Ultra Deep Full-face coverage.
Exclusive skin booster formula
Redensity we Contains 8 amino acids + 3 antioxidants · exclusive in the industry.
Reversibility
Hylenex Hyaluronidase can dissolve the filler at any time · safe and controllable.
Low-swelling Preserved Network
Preserves the HA’s natural long-chain structure · Post-injection swelling is significantly lower than with highly cross-linked HA.
Long-lasting results
RHA The series maintains results for 12–18 months in dynamic areas · Significantly longer than non-RHA alternatives in the same zones.
Teosyal® vs Juvéderm® / Restylane® / Belotero® Full comparison
| Brand | Manufacturer | Core technique | Clinical characteristics | Maintain |
|---|---|---|---|---|
| Teosyal® | Teoxane (Switzerland) | RHA + Preserved Network | First choice for high-movement areas · FDA-designated for the tear trough | 12-18 months |
| Juvéderm® | Allergan / AbbVie | Vycross / Hylacross | Smooth and long-lasting · preferred for cheekbone augmentation with Voluma | 12-24 months |
| Restylane® | Galderma | NASHA / OBT (XpresHAn) | Particulate structure · Strong lifting support | 9-18 months |
| Belotero® | Merz | CPM Monophasic multi-density | Softest formula · superficial fine lines / low Tyndall effect risk | 6-12 months |
Note: Our physician selects the appropriate product based on each patient’s treatment area, anatomical structure, and dynamic movement patterns. In some cases, multi-brand combination protocols are used to leverage the distinct rheological advantages of each filler. See also: clinical applications of Teosyal RHA in dynamic areas of Asian faces.
Why Trust Luowei Medical Aesthetics Clinic for Teosyal Dermal Filler in Nanjing?
Google's E-E-A-T framework evaluates medical content across four dimensions. The following are the specific credentials behind every claim made on this page.
Real clinical experience
- 10+ years dedicated to HA filler clinical practice
- Complete Before & After photo documentation for every patient
- Expertise in facial anatomy and dynamic area assessment
- Teosyal Complete clinical experience across all eight product lines (RHA 1–4 / Redensity I–II / Kiss / Ultra Deep)
Industry authority certifications
- Teoxane Teosyal Clinical Research Investigator
Transparent and verifiable
- Written informed consent form signed before every injection
- Teosyal Products sourced through Teoxane’s authorized Chinese cold-chain distribution
- Hylenex Hyaluronidase always on hand for emergency use
Teosyal® Not “just another HA” — a differentiated choice for high-mobility areas
Teosyal Juvéderm®, Restylane®, and Belotero are all excellent cross-linked HA fillers; however, Teoxane’s RHA® resilient technology combined with the Preserved Network is A truly differentiated approach for dynamic areas — mouth corners, nasolabial folds, perioral region, crow’s feet — especially for patients who smile and speak frequently, such as teachers, sales professionals, and presenters.. Redensity II This is currently the only NMPA-registered HA specifically indicated for tear trough treatment, and it holds an irreplaceable clinical role for thin Asian skin.
Our physician at Multi-brand HA combination plan (Teosyal / Juvéderm / Restylane / Belotero) clinical experience enables our physician's to precisely match the right product to your specific area, anatomy, and dynamic characteristics — rather than applying a one-size-fits-all approach.
Teosyal Filler Pricing · Payment Options — Nanjing
pricing is based on syringe(s) pricing applies, varying by product line, volume, and whether combination treatment is used.A personalized quote is provided by our physician following your free 30-minute consultation.
Teosyal Priced per syringe · 1 ml (RHA / Kiss / Redensity II) / 3 ml (Ultra Deep large-volume syringe)
Tear troughs: 1 syringe · Nasolabial folds: 1–2 syringes · Lips: 1 syringe · Nasal base / jawline: 2–3 syringes · Redensity we skin booster: 3 sessions
- Payment is made at the clinic, after the consultation and before treatment begins
- Nothing is paid in advance, and no deposit is required to hold an appointment
- Cosmetic treatment is a self-pay item and is not covered by public medical insurance in China
- All new clients receive a complimentary 30-minute complimentary Consultation & Assessment
Common risks · contraindications · vascular occlusion prevention
Transparency in aesthetic medicine is itself a mark of expertise and trustworthiness. We openly share all potential reactions, serious risks, contraindications, and absolute exclusions — so you are fully informed before your consultation. Our physician reviews each point with you personally before every injection.
Common reactions (typically occur shortly after injection)
- redness and swelling at injection sites / small needle marks (1-3 hours to resolve)
- temporary swelling (Peak swelling Days 1–3 · fully resolved in 7–14 days; Teosyal Preserved Network typically produces less swelling than heavily cross-linked alternatives
- bruising (Approximately 10–20% likelihood · Resolves in 5–10 days · Arnica may help speed recovery)
- tenderness at injection sites (24-48 hours · similar to a mild muscle ache)
- Palpable small nodules (early-stage gel not yet fully hydrated · naturally softens within 2–4 weeks)
- Minor asymmetry (Normal during the swelling resolution phase · 14-day follow-up assessment)
Serious Risks (rare but essential to disclose)
- Vascular Occlusion— Extremely rare (< 0.05%) but the most serious complication of HA filler · Presents as severe pain, skin blanching / livid discoloration, and mottled bruising · Hylenex hyaluronidase can dissolve the filler within a 4-hour golden window · Severe cases may result in skin necrosis or vision loss
- Tyndall effect (bluish discoloration visible through skin)— HA A bluish shadow caused by light scattering when filler is placed too superficially · Most commonly seen in the tear trough and shallow perioral area · Correctable immediately with Hylenex · Teosyal Redensity II carries a lower Tyndall effect risk in the tear trough
- Foreign body granuloma— Rare · most often associated with biofilm infection · requires combined antibiotic and Hylenex management
- Allergic reaction— Extremely rare · Products containing Lidocaine require screening for anaesthetic allergy history
- delayed-onset nodules— Rare · may appear months after injection · often immune-mediated · treatable with dissolving agent
- infection— Rare · Preventable with strict aseptic technique · Relatively higher incidence in the metabolically active lip area
Absolute contraindications (do not proceed)
- Pregnancy / breastfeeding
- Known allergy to hyaluronic acid or lidocaine
- Autoimmune conditions affecting the skin (lupus erythematosus / scleroderma / sarcoidosis)
- Active infection at the injection site / active herpes simplex outbreak
- Recent injection of non-HA filler materials that may conflict (PMMA / silicone oil / autologous fat)
- Keloid or abnormal scarring tendency
- Acute fever / active flu
- Minors (< 21 years of age, except for specific medical indications)
Our physician’s Mandatory Safety Protocol
- Every patient undergoes a dynamic anatomical assessment + medical history review + current medications + prior filler history (including non-HA fillers) before injection
- A written informed consent form is signed before every injection session
- All Teosyal products are sourced from Teoxane’s Chinese authorized cold-chain distribution · Maintained at 2–25°C throughout
- All Teosyal injections are performed personally by our physician — never delegated to a technician
- High-risk zones (nose, tear troughs, glabella, temples) prioritize 27G blunt cannula technique
- stocked on-site at the clinic Hylenex Hyaluronidase (150 U/ml)4-hour golden window vascular occlusion emergency response
- Aspiration test before each injection · slow, low-pressure delivery · micro-bolus technique · real-time dynamic expression verification
- Follow-up at 14 days post-injection · Clinical photos taken · Assessment for any fine-tuning if needed
Where the medical claims on this page come from
Everything above about Teosyal® rests on published evidence rather than on our own word. The sources below are the ones behind those statements: peer-reviewed papers indexed in PubMed, and guidance written for patients by dermatology academies and national health services. Read them before you decide — and bring any of them to your consultation.
- Peer-reviewedHyaluronic Acid Dermal Filler-Associated Vascular Occlusion-A Review of Prevention and Management Strategies
- Peer-reviewedHyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations
- Peer-reviewedBotulinum toxin type A for facial wrinkles
- Patient guidanceDermal fillers: Overview
- Patient guidanceBotulinum toxin: Overview
- Patient guidanceNeedle-free filler risks: What you should know
What these references can and cannot tell you. They describe what is known about the treatment itself — how well it tends to work, how long results last, and what can go wrong. They are not an assessment of this clinic, and no published study can tell you whether it suits your skin type, anatomy, or medical history. That judgement comes from the physician who examines you in person, and it may well be “not this one”.